Replies to post #10989 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Slim, first thing first...offering was made as a hedge against low ball offers of a BO. If there are no takers for their BO asking price, at least they have a fund to start GIA. Of course it’s going to be followed by another offering if they still can’t get a good offer. I doubt it will come to that. Just imagine the potential of Voclosporin to offer a new replacement for cyclosporine in all indications that cyclosporine treats. All they need maybe is a phase 3 trial for any indication there of because its safety and efficacy have already been established. And of course there is that unmet medical need in LN and perhaps other kidney conditions in the horizon. Covid19 is the only stumbling block against all drugs in development today.

[Ganz]

Hold out Slim, AUPH isn’t a profitable company currently and the business world is a brutal environment given the current situation.Companies with rock solid balance sheets are furloughing and firing employees, gold is at an all time high.Cash is king right now and the only solution for uncertainty. So, all we have is cash and the ability to combat LN and DES.
Q3 will bring another mediocre quarter....after that, hold on to your seat, the waiting will pay off.